|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1001 to 1100 out of 1262 for Ezh2

<< First    < Previous  |  Next >    Last >>
0.074s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Protein
Q61188
Organism: Mus musculus/domesticus
Length: 746  
Fragment?: false
•
•
•
•
•
Protein
Q3TZH6
Organism: Mus musculus/domesticus
Length: 746  
Fragment?: false
•
•
•
•
•
Protein
Q571L5
Organism: Mus musculus/domesticus
Length: 779  
Fragment?: true
•
•
•
•
•
Protein
D3Z774
Organism: Mus musculus/domesticus
Length: 707  
Fragment?: false
•
•
•
•
•
Protein
Q6AXH7
Organism: Mus musculus/domesticus
Length: 742  
Fragment?: false
•
•
•
•
•
Protein
A0A0N4SUQ8
Organism: Mus musculus/domesticus
Length: 127  
Fragment?: true
•
•
•
•
•
HT Experiment
E-GEOD-60660 | Expression data from Ezh2 epithelial knock-out mouse lungs at E14.5
Series Id: GSE60660
Experiment Type: transcription profiling by array
Study Type: WT vs. Mutant
Source: ArrayExpress
•
•
•
•
•
Publication
35884510 | J:326825
 
First Author: Versemann L
Year: 2022
Journal: Cancers (Basel)
Title: TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer.
Volume: 14
Issue: 14
•
•
•
•
•
HT Experiment
E-GEOD-74538 | Transcription profiling of midbrain samples from Ezh2 knockout mouse embryos
Series Id: GSE74538
Experiment Type: transcription profiling by array
Study Type: WT vs. Mutant
Source: ArrayExpress
•
•
•
•
•
HT Experiment
GSE80222 | Polycomb Ezh2 controls the fate of GABAergic neurons in the embryonic cerebellum
 
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
•
•
•
•
•
HT Experiment
E-GEOD-30076 | Transcription profiling by array of mouse heart mutant for Ezh2
Series Id: GSE30076
Experiment Type: transcription profiling by array
Study Type: WT vs. Mutant
Source: ArrayExpress
•
•
•
•
•
Protein
Q61188-2
Organism: Mus musculus/domesticus
Length: 704  
Fragment?: false
•
•
•
•
•
HT Experiment
GSE109578 | Expression data from mouse adrenal glands extracted from wild-type and sf1:Cre; Ezh2 Fl/Fl (KO) adrenals
 
Experiment Type: transcription profiling by array
Study Type: WT vs. Mutant
Source: GEO
•
•
•
•
•
HT Experiment
E-GEOD-70440 | Loss of EZH2 results in precocious mammary gland development and the activation of STAT5-dependent genes
Series Id: GSE70440
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: ArrayExpress
•
•
•
•
•
Publication
25686104 | J:227937
First Author: Bitler BG
Year: 2015
Journal: Nat Med
Title: Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers.
Volume: 21
Issue: 3
Pages: 231-8
•
•
•
•
•
Publication
37729434 | J:343472
First Author: Wu G
Year: 2023
Journal: Sci Transl Med
Title: TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence.
Volume: 15
Issue: 714
Pages: eadi7244
•
•
•
•
•
HT Experiment
GSE150032 | Ezh2 is essential for the generation of functional yolk sac derived erythro-myeloid progenitors [RNA-seq]
 
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
•
•
•
•
•
Publication
24516139 | J:206821
First Author: Gonzalez ME
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: EZH2 expands breast stem cells through activation of NOTCH1 signaling.
Volume: 111
Issue: 8
Pages: 3098-103
•
•
•
•
•
Publication
32619406 | J:296312
First Author: Yuan H
Year: 2020
Journal: Cancer Cell
Title: SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways.
Volume: 38
Issue: 3
Pages: 350-365.e7
•
•
•
•
•
HT Experiment
E-GEOD-65082 | Ezh2 maintains proliferation, transcriptional integrity, and the timing of late differentiation during mouse retina development
Series Id: GSE65082
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: ArrayExpress
•
•
•
•
•
Publication
28746871 | J:254287
First Author: Zingg D
Year: 2017
Journal: Cell Rep
Title: The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy.
Volume: 20
Issue: 4
Pages: 854-867
•
•
•
•
•
Publication
30487290 | J:268971
First Author: Serresi M
Year: 2018
Journal: J Exp Med
Title: Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities.
Volume: 215
Issue: 12
Pages: 3115-3135
•
•
•
•
•
Publication
29351847 | J:257573
First Author: Wan L
Year: 2018
Journal: Mol Cell
Title: Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function.
Volume: 69
Issue: 2
Pages: 279-291.e5
•
•
•
•
•
Publication
30297712 | J:267569
First Author: Wu S
Year: 2018
Journal: Nat Commun
Title: SWI/SNF catalytic subunits' switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells.
Volume: 9
Issue: 1
Pages: 4116
•
•
•
•
•
Publication
19893569 | J:259107
First Author: Wu ZL
Year: 2010
Journal: Cell Death Differ
Title: Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression.
Volume: 17
Issue: 5
Pages: 801-10
•
•
•
•
•
Publication
29555646 | J:264757
First Author: Neo WH
Year: 2018
Journal: Blood
Title: Cell-extrinsic hematopoietic impact of Ezh2 inactivation in fetal liver endothelial cells.
Volume: 131
Issue: 20
Pages: 2223-2234
•
•
•
•
•
Publication
34655667 | J:314035
 
First Author: Chen F
Year: 2022
Journal: Cancer Lett
Title: EZH2 inhibition confers PIK3CA-driven lung tumors enhanced sensitivity to PI3K inhibition.
Volume: 524
Pages: 151-160
•
•
•
•
•
HT Experiment
GSE58998 | The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation
Series Id: E-GEOD-58998
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
•
•
•
•
•
HT Experiment
GSE179186 | Single-cell RNA sequencing reveals the novel role of Ezh2 in NK cell maturation and function
 
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
•
•
•
•
•
HT Experiment
GSE233151 | Single cell RNA-seq analysis in mouse embryonic medial ganglionic eminence (MGE) under deletion of Ezh2 gene (10X Genomics Multiome)
 
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
•
•
•
•
•
Publication
22233633 | J:225016
 
First Author: Herrera-Merchan A
Year: 2012
Journal: Nat Commun
Title: Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease.
Volume: 3
Pages: 623
•
•
•
•
•
Publication
24108699 | J:206333
First Author: Wang A
Year: 2013
Journal: J Immunol
Title: Cutting edge: Smad2 and Smad4 regulate TGF-β-mediated Il9 gene expression via EZH2 displacement.
Volume: 191
Issue: 10
Pages: 4908-12
•
•
•
•
•
Publication
25600873 | J:222807
     
First Author: de Vries NA
Year: 2015
Journal: Cell Rep
Title: Prolonged Ezh2 Depletion in Glioblastoma Causes a Robust Switch in Cell Fate Resulting in Tumor Progression.
•
•
•
•
•
Publication
36966198 | J:334506
First Author: Gleneadie HJ
Year: 2023
Journal: Commun Biol
Title: Endogenous bioluminescent reporters reveal a sustained increase in utrophin gene expression upon EZH2 and ERK1/2 inhibition.
Volume: 6
Issue: 1
Pages: 318
•
•
•
•
•
Publication
25395428 | J:220776
First Author: Xu B
Year: 2015
Journal: Blood
Title: Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia.
Volume: 125
Issue: 2
Pages: 346-57
•
•
•
•
•
Publication
38001678 | J:343131
 
First Author: Zhang M
Year: 2023
Journal: Cancers (Basel)
Title: Regulation of EZH2 Expression by INPP4B in Normal Prostate and Primary Prostate Cancer.
Volume: 15
Issue: 22
•
•
•
•
•
Publication
34589402 | J:354419
First Author: Lv Q
Year: 2021
Journal: Acta Pharm Sin B
Title: Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation.
Volume: 11
Issue: 9
Pages: 2880-2899
•
•
•
•
•
Publication
27312177 | J:236800
First Author: Zhang H
Year: 2016
Journal: Cancer Discov
Title: Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer.
Volume: 6
Issue: 9
Pages: 1006-21
•
•
•
•
•
Publication
28536141 | J:245815
First Author: Liu H
Year: 2017
Journal: Mol Cancer Res
Title: MELK and EZH2 Cooperate to Regulate Medulloblastoma Cancer Stem-like Cell Proliferation and Differentiation.
Volume: 15
Issue: 9
Pages: 1275-1286
•
•
•
•
•
Publication
29035360 | J:251677
First Author: Rondinelli B
Year: 2017
Journal: Nat Cell Biol
Title: EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation.
Volume: 19
Issue: 11
Pages: 1371-1378
•
•
•
•
•
Publication
32332097 | J:297144
First Author: Dudakovic A
Year: 2020
Journal: J Biol Chem
Title: Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2.
Volume: 295
Issue: 23
Pages: 7877-7893
•
•
•
•
•
HT Experiment
E-GEOD-52016 | EZH2 controls mammary differentiation independently of its methyltransferase activity through controlling genomic STAT5 access
Series Id: GSE52016
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: ArrayExpress
•
•
•
•
•
Publication
17344414 | -
First Author: Bracken AP
Year: 2007
Journal: Genes Dev
Title: The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells.
Volume: 21
Issue: 5
Pages: 525-30
•
•
•
•
•
Publication
18281287 | -
First Author: Wong CF
Year: 2008
Journal: J Biol Chem
Title: MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis.
Volume: 283
Issue: 15
Pages: 9836-43
•
•
•
•
•
Publication
33589750 | J:305487
First Author: Berg JL
Year: 2021
Journal: Leukemia
Title: EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity.
Volume: 35
Issue: 5
Pages: 1521-1526
•
•
•
•
•
Publication
24367611 | -
First Author: Wu H
Year: 2013
Journal: PLoS One
Title: Structure of the catalytic domain of EZH2 reveals conformational plasticity in cofactor and substrate binding sites and explains oncogenic mutations.
Volume: 8
Issue: 12
Pages: e83737
•
•
•
•
•
Publication
26235356 | J:227730
First Author: McCleland ML
Year: 2015
Journal: J Pathol
Title: Cdk8 deletion in the Apc(Min) murine tumour model represses EZH2 activity and accelerates tumourigenesis.
Volume: 237
Issue: 4
Pages: 508-19
•
•
•
•
•
Interaction Experiment
Etchegaray JP (2006)
Description: The polycomb group protein EZH2 is required for mammalian circadian clock function.
•
•
•
•
•
Interaction Experiment
Tonini T (2004)
Description: Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A.
•
•
•
•
•
Interaction Experiment
Consalvi S (2017)
Description: Praja1 E3 ubiquitin ligase promotes skeletal myogenesis through degradation of EZH2 upon p38 activation.
•
•
•
•
•
HT Experiment
E-GEOD-53627 | Disruption of H3K27me3 through loss of EZH1 and EZH2 accelerates progression of hepatosteatosis to fatal liver fibrosis
Series Id: GSE53627
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: ArrayExpress
•
•
•
•
•
HT Experiment
GSE79035 | An oncogenic Ezh2 mutation cooperates with particular genetic alterations to induce tumors in mice and redistributes H3K27m3 through the genome [RNA-seq]
Series Id: E-GEOD-79035
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
•
•
•
•
•
Publication
18086877 | -
First Author: Cao R
Year: 2008
Journal: Mol Cell Biol
Title: Role of hPHF1 in H3K27 methylation and Hox gene silencing.
Volume: 28
Issue: 5
Pages: 1862-72
•
•
•
•
•
Publication
17259173 | J:121147
First Author: Kim SY
Year: 2007
Journal: J Biol Chem
Title: Developmental regulation of Eed complex composition governs a switch in global histone modification in brain.
Volume: 282
Issue: 13
Pages: 9962-72
•
•
•
•
•
Interaction Experiment
Attwooll C (2005)
Description: A novel repressive E2F6 complex containing the polycomb group protein, EPC1, that interacts with EZH2 in a proliferation-specific manner.
•
•
•
•
•
Allele
Ezh2<em1Jbn> | MGI:6259828
Name: enhancer of zeste 2 polycomb repressive complex 2 subunit; endonuclease-mediated mutation 1, Jeffrey Baron
Allele Type: Endonuclease-mediated
Attribute String: Humanized sequence
•
•
•
•
•
Allele
Ezh2<em1Jiaf> | MGI:7610894
Name: enhancer of zeste 2 polycomb repressive complex 2 subunit; endonuclease-mediated mutation 1, Jill A Fahrner
Allele Type: Endonuclease-mediated
Attribute String: Humanized sequence, Null/knockout
•
•
•
•
•
Publication
12123576 | -
First Author: Mak W
Year: 2002
Journal: Curr Biol
Title: Mitotically stable association of polycomb group proteins eed and enx1 with the inactive x chromosome in trophoblast stem cells.
Volume: 12
Issue: 12
Pages: 1016-20
•
•
•
•
•
Publication
12689588 | -
First Author: Silva J
Year: 2003
Journal: Dev Cell
Title: Establishment of histone h3 methylation on the inactive X chromosome requires transient recruitment of Eed-Enx1 polycomb group complexes.
Volume: 4
Issue: 4
Pages: 481-95
•
•
•
•
•
Publication
12649488 | J:82788
First Author: Plath K
Year: 2003
Journal: Science
Title: Role of histone H3 lysine 27 methylation in X inactivation.
Volume: 300
Issue: 5616
Pages: 131-5
•
•
•
•
•
Publication
14752160 | J:90454
First Author: Mak W
Year: 2004
Journal: Science
Title: Reactivation of the paternal X chromosome in early mouse embryos.
Volume: 303
Issue: 5658
Pages: 666-9
•
•
•
•
•
Publication
16357870 | -
First Author: Viré E
Year: 2006
Journal: Nature
Title: The Polycomb group protein EZH2 directly controls DNA methylation.
Volume: 439
Issue: 7078
Pages: 871-4
•
•
•
•
•
Interaction Experiment
Lambrot R (2012)
Description: Specialized Distribution of the Histone Methyltransferase Ezh2 in the Nuclear Apical Region of Round Spermatids and Its Interaction with the Histone Variant H1t2.
•
•
•
•
•
Allele
Ezh2<tm1Smoc> | MGI:7289566
Name: enhancer of zeste 2 polycomb repressive complex 2 subunit; targeted mutation 1, Shanghai Model Organisms Center
Allele Type: Targeted
Attribute String: Conditional ready, No functional change
•
•
•
•
•
Allele
Tg(Lck-EZH2*Y641F)1Rkh | MGI:7491716
Name: transgene insertion 1, R Keith Humphries
Allele Type: Transgenic
Attribute String: Epitope tag, Inserted expressed sequence
•
•
•
•
•
HT Experiment
GSE141181 | H3K27me3 maintains the transcription program during epigenetic reprogramming in the mouse germ line [RNA-seq]
 
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
•
•
•
•
•
Publication
15516932 | J:94241
First Author: Umlauf D
Year: 2004
Journal: Nat Genet
Title: Imprinting along the Kcnq1 domain on mouse chromosome 7 involves repressive histone methylation and recruitment of Polycomb group complexes.
Volume: 36
Issue: 12
Pages: 1296-300
•
•
•
•
•
Publication
15684044 | -
First Author: Kuzmichev A
Year: 2005
Journal: Proc Natl Acad Sci U S A
Title: Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation.
Volume: 102
Issue: 6
Pages: 1859-64
•
•
•
•
•
Publication
16415857 | J:129406
First Author: Kalantry S
Year: 2006
Journal: Nat Cell Biol
Title: The Polycomb group protein Eed protects the inactive X-chromosome from differentiation-induced reactivation.
Volume: 8
Issue: 2
Pages: 195-202
•
•
•
•
•
Strain
MGI:6354765 | C57BL/6JSmoc-Ezh2<tm1Smoc>/Smoc
Attribute String: coisogenic, mutant strain, targeted mutation
•
•
•
•
•
Allele
Gt(ROSA)26Sor<em61(CAG-EZH2,-luc,-tdTomato)Smoc> | MGI:7290070
Name: gene trap ROSA 26, Philippe Soriano; endonuclease-mediated mutation 61, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Conditional ready, Inserted expressed sequence, Reporter
•
•
•
•
•
Publication
16224021 | -
First Author: Cha TL
Year: 2005
Journal: Science
Title: Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3.
Volume: 310
Issue: 5746
Pages: 306-10
•
•
•
•
•
Publication
15077161 | -
First Author: Tonini T
Year: 2004
Journal: Oncogene
Title: Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A.
Volume: 23
Issue: 28
Pages: 4930-7
•
•
•
•
•
DO Term
DOID:14731 | Weaver syndrome
•
•
•
•
•
Genotype
Genotype
Symbol: Ezh2/Ezh2
Background: C57BL/6J-Ezh2
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Ezh2/Ezh2<+>
Background: C57BL/6J-Ezh2
Zygosity: ht
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Ezh2/Ezh2<+>
Background: C57BL/6J-Ezh2
Zygosity: ht
Has Mutant Allele: true
•
•
•
•
•
Protein Domain
IPR041355 | Pre-SET_CXC
Type: Domain
Description: This domain is found to the N terminus of the SET domain in the EZH2 protein []. It is a zinc binding domain.
•
•
•
•
•
Strain
MGI:6354820 | C57BL/6JSmoc-Gt(ROSA)26Sor<em61(CAG-EZH2,-luc,-tdTomato)Smoc>/Smoc
Attribute String: coisogenic, mutant strain, endonuclease-mediated mutation
•
•
•
•
•
Publication
15536069 | -
First Author: Attwooll C
Year: 2005
Journal: J Biol Chem
Title: A novel repressive E2F6 complex containing the polycomb group protein, EPC1, that interacts with EZH2 in a proliferation-specific manner.
Volume: 280
Issue: 2
Pages: 1199-208
•
•
•
•
•
HT Experiment
E-GEOD-52220 | Expression data from E11.5 mouse branchial arch 1 (BA1) - comparison between Ezh2lox/lox and Wnt1Cre Ezh2lox/lox embryos
Series Id: GSE52220
Experiment Type: transcription profiling by array
Study Type: WT vs. Mutant
Source: ArrayExpress
•
•
•
•
•
Protein Domain
IPR044438 | EZH1_SET
Type: Domain
Description: This entry represents the SET domain found in EZH1.The Polycomb Repressive Complex 2 (PRC2) is a chromatin modifying complex that consists of three core components: EED, SUZ12 and one of the two histone H3K27 methyltransferases, EZH1 or EZH2 []. The PRC2 complex catalyses di- and trimethylation of histone H3 lysine 27 (H3K37me2/3), which has a repressive role. Even though EZH1 and EZH2 form similar PRC2 complexes, they exhibit contrasting repressive roles. In terms of their expression in mice, EZH1 is more abundant in nonproliferative adult organs, while EZH2 expression is tightly associated with proliferation [].
•
•
•
•
•
Protein Domain
IPR044439 | EZH2_SET
Type: Domain
Description: This entry represents the SET domain found in EZH2.The Polycomb Repressive Complex 2 (PRC2) is a chromatin modifying complex that consists of three core components: EED, SUZ12 and one of the two histone H3K27 methyltransferases, EZH1 or EZH2 []. The PRC2 complex catalyses di- and trimethylation of histone H3 lysine 27 (H3K37me2/3), which has a repressive role. Even though EZH1 and EZH2 form similar PRC2 complexes, they exhibit contrasting repressive roles. In terms of their expression in mice, EZH1 is more abundant in nonproliferative adult organs, while EZH2 expression is tightly associated with proliferation [].
•
•
•
•
•
Protein Domain
IPR032926 | EZH1
Type: Family
Description: The Polycomb Repressive Complex 2 (PRC2) is a chromatin modifying complex that consists of three core components: EED, SUZ12 and one of the two histone H3K27 methyltransferases, EZH1 or EZH2 []. The PRC2 complex catalyses di- and trimethylation of histone H3 lysine 27 (H3K37me2/3), which has a repressive role. Even though EZH1 and EZH2 form similar PRC2 complexes, they exhibit contrasting repressive roles. In terms of their expression in mice, EZH1 is more abundant in nonproliferative adult organs, while EZH2 expression is tightly associated with proliferation [].This family consists of EZH1 [].
•
•
•
•
•
Protein Domain
IPR021654 | EZH1/EZH2
Type: Family
Description: The Polycomb Repressive Complex 2 (PRC2) is a chromatin modifying complex that consists of three core components: EED, SUZ12 and one of the two histone H3K27 methyltransferases, EZH1 or EZH2 []. The PRC2 complex catalyses di- and trimethylation of histone H3 lysine 27 (H3K37me2/3), which has a repressive role. Even though EZH1 and EZH2 form similar PRC2 complexes, they exhibit contrasting repressive roles. In terms of their expression in mice, EZH1 is more abundant in nonproliferative adult organs, while EZH2 expression is tightly associated with proliferation [].
•
•
•
•
•
HT Experiment
E-GEOD-29992 | Genome-wide profiling of E12.5 cardiomyocytes RNA expression in both heterozygous control and mutant
Series Id: GSE29992
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: ArrayExpress
•
•
•
•
•
Publication
22323620 | -
First Author: Lambrot R
Year: 2012
Journal: J Androl
Title: Specialized distribution of the histone methyltransferase Ezh2 in the nuclear apical region of round spermatids and its interaction with the histone variant H1t2.
Volume: 33
Issue: 5
Pages: 1058-66
•
•
•
•
•
HT Experiment
GSE110925 | Whole kidneys at embryonic day 17.5: wildtype (WT) vs. various combinations of the conditional homozygous Ezh2-knockout (Ezh2-KO) from Six2-positive nephron progenitor cells (NPC) and/or germline Ezh1-knockout (Ezh1-KO)
 
Experiment Type: transcription profiling by array
Study Type: WT vs. Mutant
Source: GEO
•
•
•
•
•
HT Experiment
GSE32929 | Expression data from Ezh2-null erythrocyte/megakaryocyte progenitor (MEP)
Series Id: E-GEOD-32929
Experiment Type: transcription profiling by array
Study Type: WT vs. Mutant
Source: GEO
•
•
•
•
•
Protein Domain
IPR045318 | EZH1/2-like
Type: Family
Description: This entry represents a group of histone-lysine N-methyltransferases that belong to the Polycomb group (Pc-G), including:Drosophila melanogaster Enhancer of zeste E(z).Mammalian EZH-1 and EZH-2.Arabidopsis thaliana CURLY LEAF (CLF), a transcriptional repressor of floral homeotic gene AGAMOUS.Arabidopsis thaliana CLF-like.Arabidopsis thaliana MEDEA (MEA), a suppressor of endosperm development.Arabidopsis thaliana EZA1.The Polycomb Repressive Complex 2 (PRC2) is a chromatin modifying complex that consists of three core components: EED, SUZ12 and one of the two histone H3K27 methyltransferases, EZH1 or EZH2 []. The PRC2 complex catalyses di- and trimethylation of histone H3 lysine 27 (H3K37me2/3), which has a repressive role. Even though EZH1 and EZH2 form similar PRC2 complexes, they exhibit contrasting repressive roles. In terms of their expression in mice, EZH1 is more abundant in nonproliferative adult organs, while EZH2 expression is tightly associated with proliferation [].
•
•
•
•
•
Protein
Q3U575
Organism: Mus musculus/domesticus
Length: 391  
Fragment?: true
•
•
•
•
•
Protein
Q8C2I5
Organism: Mus musculus/domesticus
Length: 231  
Fragment?: true
•
•
•
•
•
DO Term
DOID:0081065 | EZB diffuse large B-cell lymphoma
•
•
•
•
•
Protein
A0A494B9V4
Organism: Mus musculus/domesticus
Length: 205  
Fragment?: true
•
•
•
•
•
Protein
A0A494B9T4
Organism: Mus musculus/domesticus
Length: 151  
Fragment?: true
•
•
•
•
•
Protein
A0A494BAH9
Organism: Mus musculus/domesticus
Length: 211  
Fragment?: true
•
•
•
•
•
Protein
A0A494BAD9
Organism: Mus musculus/domesticus
Length: 222  
Fragment?: true
•
•
•
•
•
Publication
23988457 | -
First Author: Astori A
Year: 2013
Journal: Oncotarget
Title: CXXC5 (retinoid-inducible nuclear factor, RINF) is a potential therapeutic target in high-risk human acute myeloid leukemia.
Volume: 4
Issue: 9
Pages: 1438-48
•
•
•
•
•
Publication
29928427 | -
First Author: Fang L
Year: 2018
Journal: Oncol Lett
Title: Overexpression of CXXC5 is a strong poor prognostic factor in ER+ breast cancer.
Volume: 16
Issue: 1
Pages: 395-401
•
•
•
•
•
Publication
23949225 | -
 
First Author: Lu H
Year: 2013
Journal: Cell Death Dis
Title: Enhancer of zeste homolog 2 activates wnt signaling through downregulating CXXC finger protein 4.
Volume: 4
Pages: e776
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom